Literature DB >> 19581556

Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study.

Miriam B Vos1, Mary Beth Weber, Jean Welsh, Farah Khatoon, Dean P Jones, Peter F Whitington, Craig J McClain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19581556      PMCID： PMC4259100          DOI： 10.1001/archpediatrics.2009.93

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN： 1072-4710


× No keyword cloud information.
  5 in total

1.  Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

Authors:  Ina Bergheim; Synia Weber; Miriam Vos; Sigrid Krämer; Valentina Volynets; Seline Kaserouni; Craig J McClain; Stephan C Bischoff
Journal:  J Hepatol       Date:  2008-03-14       Impact factor: 25.083

Review 2.  Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.

Authors:  Peter J Havel
Journal:  Nutr Rev       Date:  2005-05       Impact factor: 7.110

3.  Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.

Authors:  Miriam B Vos; Joel E Kimmons; Cathleen Gillespie; Jean Welsh; Heidi Michels Blanck
Journal:  Medscape J Med       Date:  2008-07-09

Review 4.  Dietary fructose and the metabolic syndrome.

Authors:  Abigale Miller; Khosrow Adeli
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

5.  Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

Authors:  Xiaosen Ouyang; Pietro Cirillo; Yuri Sautin; Shannon McCall; James L Bruchette; Anna Mae Diehl; Richard J Johnson; Manal F Abdelmalek
Journal:  J Hepatol       Date:  2008-03-10       Impact factor: 25.083
  5 in total
  22 in total

Review 1.  Role of dietary therapies in the prevention and treatment of hypertension.

Authors:  Viresh Mohanlal; Afshin Parsa; Matthew R Weir
Journal:  Nat Rev Nephrol       Date:  2012-05-15       Impact factor: 28.314

Review 2.  Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Taisa Kohut; Jennifer Panganiban
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.

Authors:  Lucia Pacifico; Valerio Nobili; Caterina Anania; Paola Verdecchia; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 5.  Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.

Authors:  Miriam B Vos; Jill L Kaar; Jean A Welsh; Linda V Van Horn; Daniel I Feig; Cheryl A M Anderson; Mahesh J Patel; Jessica Cruz Munos; Nancy F Krebs; Stavra A Xanthakos; Rachel K Johnson
Journal:  Circulation       Date:  2016-08-22       Impact factor: 29.690

Review 6.  Dyslipidemia in patients with nonalcoholic fatty liver disease.

Authors:  Hemant Chatrath; Raj Vuppalanchi; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

7.  Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.

Authors:  Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

Review 8.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

9.  Fructose takes a toll.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

Review 10.  Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.

Authors:  Kathleen E Corey; Mary E Rinella
Journal:  Dig Dis Sci       Date:  2016-03-04       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.